Strategies for monitoring and combating resistance to combination kinase inhibitors for cancer therapy

Overview of attention for article published in Genome Medicine, April 2017

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (71st percentile)

Mentioned by

twitter: 5 X users

patent: 2 patents

Readers on

mendeley: 107 Mendeley
citeulike: 2 CiteULike

Summary X Patents

So far, Altmetric has seen 2 patents that reference this research output.

Heterocyclic derivatives useful as SHP2 inhibitors

Grant US-10988466-B2

United States of America

Heterocyclic ring derivatives useful as SHP2 inhibitors

Grant US-10858359-B2

United States of America

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.